Skip to main content

Neurofibromatosis type 2.

Publication ,  Journal Article
Sathornsumetee, S; DesJardins, A; Reardon, DA; Rich, JN; Vredenburgh, JJ
Published in: Neurology
March 27, 2007

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neurology

DOI

EISSN

1526-632X

Publication Date

March 27, 2007

Volume

68

Issue

13

Start / End Page

E14

Location

United States

Related Subject Headings

  • Vestibular Nerve
  • Treatment Outcome
  • Pyrimidines
  • Piperazines
  • Neuroma, Acoustic
  • Neurology & Neurosurgery
  • Neurofibromatosis 2
  • Middle Aged
  • Magnetic Resonance Imaging
  • Imatinib Mesylate
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sathornsumetee, S., DesJardins, A., Reardon, D. A., Rich, J. N., & Vredenburgh, J. J. (2007). Neurofibromatosis type 2. Neurology, 68(13), E14. https://doi.org/10.1212/01.wnl.0000257828.56178.9f
Sathornsumetee, S., A. DesJardins, D. A. Reardon, J. N. Rich, and J. J. Vredenburgh. “Neurofibromatosis type 2.Neurology 68, no. 13 (March 27, 2007): E14. https://doi.org/10.1212/01.wnl.0000257828.56178.9f.
Sathornsumetee S, DesJardins A, Reardon DA, Rich JN, Vredenburgh JJ. Neurofibromatosis type 2. Neurology. 2007 Mar 27;68(13):E14.
Sathornsumetee, S., et al. “Neurofibromatosis type 2.Neurology, vol. 68, no. 13, Mar. 2007, p. E14. Pubmed, doi:10.1212/01.wnl.0000257828.56178.9f.
Sathornsumetee S, DesJardins A, Reardon DA, Rich JN, Vredenburgh JJ. Neurofibromatosis type 2. Neurology. 2007 Mar 27;68(13):E14.

Published In

Neurology

DOI

EISSN

1526-632X

Publication Date

March 27, 2007

Volume

68

Issue

13

Start / End Page

E14

Location

United States

Related Subject Headings

  • Vestibular Nerve
  • Treatment Outcome
  • Pyrimidines
  • Piperazines
  • Neuroma, Acoustic
  • Neurology & Neurosurgery
  • Neurofibromatosis 2
  • Middle Aged
  • Magnetic Resonance Imaging
  • Imatinib Mesylate